Related Experiment Videos
Botulinum A toxin injection as a treatment for blepharospasm
Archives of Ophthalmology (Chicago, Ill. : 1960)
|March 1, 1985
Summary
Botulinum A toxin injections effectively reduced abnormal movements in all blepharospasm patients, with effects lasting up to 170 days and showing dose dependency. Reinjection provided similar benefits, though some experienced side effects like tearing or ptosis.
Area of Science:
- Neurology
- Ophthalmology
- Pharmacology
Background:
- Blepharospasm is a focal dystonia characterized by involuntary eyelid closure.
- Botulinum toxin injections are a common treatment for blepharospasm.
Purpose of the Study:
- To evaluate the efficacy and duration of botulinum A toxin injections for blepharospasm.
- To assess the dose-response relationship and recurrence patterns of botulinum toxin treatment.
Main Methods:
- Thirty-nine patients with blepharospasm received botulinum A toxin injections in the lid and brow.
- Treatment involved up to 16 injections per patient over 24 months.
- Efficacy, duration of effect, and adverse events were monitored.
Main Results:
- All patients experienced a reduction in abnormal movements.
- The duration of effect lasted up to 170 days and was dose-dependent.
- Recurrence after reinjection showed effects similar to the initial treatment.
- Adverse events (tearing, dry eye, ptosis) occurred in 20% of injections, particularly in those with prior eyelid surgery.
Conclusions:
- Botulinum A toxin is an effective treatment for blepharospasm, providing significant reduction in abnormal movements.
- Treatment effects are dose-dependent and can be sustained through repeat injections.
- While generally safe, potential side effects should be considered, especially in patients with a history of eyelid surgery.